Aviceda Therapeutics

Cambridge, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Jan 2025

Series C

Biotechnology Health Care Life Science Neuroscience Pharmaceutical

Top Investors

Catalio Capital ManagementTCG CrossoverBlue OwlOrbiMedJeito Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aviceda Therapeutics

Who are Aviceda Therapeutics's investors?

Aviceda Therapeutics's investors include Catalio Capital Management, TCG Crossover, Blue Owl, OrbiMed, Jeito Capital.

Where is Aviceda Therapeutics headquartered?

Aviceda Therapeutics is headquartered in Cambridge, United States.

What does Aviceda Therapeutics do?

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

What stage is Aviceda Therapeutics at?

Aviceda Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 7, 2025.

MLA

"Aviceda Therapeutics — Funding & Investors." VCBacked, January 7, 2025, https://www.vcbacked.co/company/aviceda-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Aviceda Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/aviceda-therapeutics

Wikipedia (cite web)

{{cite web |title=Aviceda Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aviceda-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 7, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.